Skip to content
OpenCapital
Get started

Ardelyx ARDX Product sales, net — Total revenues

Other product segments

IBSRELA
$70.07M+57.8%
XPHOZAH
$23.3M-0.5%
Non-cash royalty revenue related to the sale of future royalties
$695K-32.3%
Product supply revenue
$354K+39.4%
Licensing revenue
$51K-99.0%

Similar metrics at other companies

BioCryst Pharmaceuticals logo
BCRXProduct sales, net — Total revenues
$151.4M+5.3%
Tarsus Pharmaceuticals, Inc. logo
TARSProduct sales, net — Total revenues
$145.39M+85.6%
Travere Therapeutics, Inc. logo
TVTXTotal net product sales — Total Revenue
$124.49M+64.1%
Aurinia Pharmaceuticals logo
AUPHNet product sales — Revenue
$73.56M+22.7%
Mirum Pharmaceuticals, Inc. logo
MIRMProduct sales, net — Product sales, net
$159.88M+43.3%
XER
XERSProduct revenue, net — Product revenue, net
$82.45M+42.6%

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+25.5%
Enterprise value$1.71B+27.1%
P/S3.6×+0.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%—
Net margin-13.6%—
FCF margin-40.9%—

Returns & leverage

See full
Return on equity-39.5%—
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's product sales, net — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's product sales, net — total revenues?
Ardelyx (ARDX) reported product sales, net — total revenues of $93.37M in Q1 2026.
How has Ardelyx's product sales, net — total revenues changed year-over-year?
Ardelyx's product sales, net — total revenues increased by 37.7% year-over-year, from $67.81M to $93.37M.
What does product sales, net — total revenues mean?
This metric represents the total net revenue generated from the sale of pharmaceutical products after accounting for returns, allowances, and rebates. It serves as a primary indicator of market adoption and commercial success for the company's therapeutic portfolio. Tracking this figure allows investors to assess the growth trajectory and revenue-generating capacity of the company's core commercial assets.